Maple Capital Management’s Biogen BIIB Stock Holding History

Maple Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-670	Closed	-$229K	–	105
2021 Q2	$229K	Buy	+670	New	+$203K	0.03%	103
2020 Q2	–	Sell	-781	Closed	-$247K	–	99
2020 Q1	$247K	Hold	781	–	–	0.06%	80
2019 Q4	$232K	Sell	781 -84	-10%	-$23.3K	0.04%	112
2019 Q3	$201K	Hold	865	–	–	0.04%	116
2019 Q2	$202K	Hold	865	–	–	0.05%	119
2019 Q1	$204K	Hold	865	–	–	0.05%	118
2018 Q4	$260K	Hold	865	–	–	0.07%	102
2018 Q3	$306K	Sell	865 -4	-0.5%	-$1.38K	0.07%	104
2018 Q2	$252K	Sell	869 -15	-2%	-$4.22K	0.06%	114
2018 Q1	$242K	Sell	884 -10	-1%	-$3.1K	0.06%	120
2017 Q4	$285K	Buy	894 +25	+3%	+$8.02K	0.07%	115
2017 Q3	$272K	Hold	869	–	–	0.07%	117
2017 Q2	$236K	Hold	869	–	–	0.07%	123
2017 Q1	$238K	Sell	869 -20	-2%	-$5.66K	0.07%	122
2016 Q4	$252K	Buy	889 +4	+0.5%	+$1.19K	0.08%	112
2016 Q3	$277K	Buy	885 +50	+6%	+$14.8K	0.09%	107
2016 Q2	$202K	Hold	835	–	–	0.07%	109
2016 Q1	$217K	Hold	835	–	–	0.08%	110
2015 Q4	$256K	Hold	835	–	–	0.09%	113
2015 Q3	$244K	Buy	835 +20	+2%	+$6.61K	0.09%	112
2015 Q2	$329K	Sell	815 -22	-3%	-$8.83K	0.11%	101
2015 Q1	$353K	Sell	837 -163	-16%	-$64.2K	0.12%	96
2014 Q4	$339K	Buy	+1,000	New	+$324K	0.12%	97

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Maple Capital Management's BIIB Position: Q3 2021 in Review

Maple Capital Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 670 shares — an estimated $229K sold.

Maple Capital Management first reported a position in BIIB in Q4 2014 and held it in 23 quarters. The position peaked at $353K in Q1 2015. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Maple Capital Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
Maple Capital Management sold 670 Biogen shares in Q3 2021, an estimated $229K.
Maple Capital Management first reported a position in Biogen in Q4 2014 and held it in 23 quarters.
Maple Capital Management's Biogen position peaked at $353K in Q1 2015.
1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Maple Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.